SecBot SecBot
13F-HR ·Filed Aug 13, 2026

MS

MORGAN STANLEY
BULLISH
Impact 6/10
Horizonmonths Processed3mo ago SEC0000895421-26-000243
13F from Morgan Stanley (mega_passive)
Actionable Insight ▲ Bullish

Monitor the performance of new positions in AbSci, Eos Energy, and Harmony Biosciences, as these represent fresh thematic bets. The significant increase in Standard Lithium and Canadian Natural Resources signals a bullish view on lithium and energy. The strong earnings context supports a positive outlook, but watch for any subsequent filings that might adjust these positions.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$218.38
T+0 close · Aug 13, 2026 · via day close
Latest settled
−16.92%
T+60 · $181.44
Vs SPY
−11.68%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 13 $218.38entry
  2. T+1 · 3mo ago −0.47%α −0.27% · $217.36
  3. T+5 · 3mo ago −5.00%α −3.04% · $207.45
  4. T+20 · 2mo ago −1.83%α −0.08% · $214.38
  5. T+60 · 11d ago −16.92%α −11.68% · $181.44
Loading chart...

Executive Summary

Morgan Stanley's Q2 2026 13F filing reveals a portfolio with a total value of approximately $1.89 trillion, filed shortly after the company reported record quarterly results. The filing shows significant new positions in AbSci Corporation, Eos Energy Enterprises, and Harmony Biosciences, alongside substantial increases in existing positions like Rhythm Pharmaceuticals and Standard Lithium. The portfolio also reflects a rotation into energy and materials sectors, with notable increases in Canadian Natural Resources and Permian Resources, while reducing exposure to some financial and tech names. The filing is consistent with the firm's strong earnings report, which saw record net revenues of $21.3B and a $20B buyback authorization, suggesting a confident deployment of capital into growth and thematic areas.

Key Facts

  • Total portfolio value of approximately $1.89 trillion as of June 30, 2026.
  • New positions include AbSci Corporation ($11.6M), Eos Energy Enterprises ($7.4M), and Harmony Biosciences ($7.4M).
  • Significant increases in Rhythm Pharmaceuticals (853,492 shares), Standard Lithium (1.47M shares), and Canadian Natural Resources (10.67M shares).
  • Top holdings by value include NVIDIA ($23.0B), Amazon ($2.0B), Chevron ($3.2B), and Berkshire Hathaway ($5.8B).
  • Filing follows record Q2 2026 earnings with net revenues of $21.3B (+27% YoY) and EPS of $3.46, beating consensus by 18%.
  • Board authorized a $20B multi-year buyback and raised quarterly dividend by $0.15 to $1.15.

Financial Impact

Portfolio value of approximately $1.89 trillion as of June 30, 2026, reflecting deployment of capital into new and increased positions across multiple sectors.

portfolio allocationsector exposure

Risk Factors

  • New positions in early-stage companies (AbSci, Eos Energy) carry high volatility and binary risk.
  • Concentration in NVIDIA ($23B) and other mega-cap tech exposes the portfolio to sector-specific downturns.
  • Large positions in lithium and energy are sensitive to commodity price fluctuations.

Market Snapshot

Exchange
NYSE
Sector
Security Brokers, Dealers & Flotation Companies
Analyst Consensus
61% bullish (33 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
13F-HR Filing (Primary)0000895421-26-000243
Document: 0000895421-26-000243-index.html0000895421-26-000243
Document: 0000895421-26-000243.txt0000895421-26-000243

Track record

15 reports on MS

Performance horizon

1 of 4 bullish or bearish reports moved the stock their way by T+1. Best: +1.72% at T+1 after the Oct 27, 2026 report. 1 of 4 went positive at some point.

Filters
  1. Nov 13, 20263d ago 13F-HR Neutral 4/10 Entry $190.65 Now $190.65 −0.00% settles Nov 17
  2. Nov 6, 202610d ago 144 Neutral 2/10 Entry $187.10 to $187.56 Now $190.65 +1.90% ▲ +0.25% +0.61% vs SPY
  3. Oct 27, 202620d ago Institutional Cluster Bullish 4/10 Entry $186.91 to $190.13 Now $190.65 +2.00% ▲ +1.72% +1.38% vs SPY
  4. Oct 16, 20264w ago 144 Neutral 2/10 Entry $178.47 to $180.40 Now $190.65 +6.82% ▲ +1.08% +0.75% vs SPY
  5. Oct 14, 20264w ago 8-K Neutral 5/10 Entry $181.51 to $182.10 Now $190.65 +5.04% ▲ +0.33% +0.04% vs SPY
  6. Oct 8, 20265w ago ANALYST-UPGRADE Neutral 1/10 Entry $187.44 to $190.02 Now $190.65 +1.71% ▲ +1.38% +0.78% vs SPY
  7. Aug 14, 202613w ago Court Ruling Neutral 2/10 Entry $218.21 to $217.55 Now $190.65 −12.63% ▼ −0.30% +0.37% vs SPY
  8. Aug 13, 202613w ago 13F-HR Bullish 6/10 Viewing Entry $218.38 to $217.36 Now $190.65 −12.70% ▼ −0.47% −0.27% vs SPY
  9. Jul 17, 202617w ago Insider Cluster Neutral 3/10 Entry $210.94 to $216.40 Now $190.65 −9.62% ▲ +2.59% +1.75% vs SPY
  10. Jul 15, 202617w ago 8-K Bullish 6/10 Entry $228.55 to $218.37 Now $190.65 −16.58% ▼ −4.45% −3.91% vs SPY
Showing 10 of 15

US Market Status

Market Closed · Opens Wed (12h 4m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 13, 2026